Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 745-752

  Cundy, Kenneth C ^a   Bidgood, Alison M ^a   Lynch, Geoffrey ^a   Shaw, Jeng Pyng ^a   Griffin, Linda ^a   Lee, William A ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; HERPES; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; CARBON RADIOISOTOPES; CYTOSINE; FEMALE; INJECTIONS, INTRAVENOUS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; VIRUS DISEASES;

EID: 0030054976     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J. J. Bronson, L. M. Ferrara, M. J. M. Hitchcock, H.-T. Ho, K. L. Woods, I. Ghazzouli, E. R. Kern, K. F. Soike, and J. C. Martin: (S)-1-(3-Hydroxy-2-(phosphonylmethoxy)propyl) cytosine (HPMPC): a potent antiherpesvirus agent. In "Immunobiology and Prophylaxis of Human Herpesvirus Infections" (C. Lopez et al., eds.). Plenum Press, New York, 1990.
2. J. P. Lalezari, W. L. Drew, E. Glutzer, C. James, D. Miner, J. Flaherty, P. E. Fisher, K. C. Cundy, J. Hannigan, J. C. Martin, and H. S. Jaffe: (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J. Infect. Dis. 171, 788-796 (1995).
3. M. A. Polis, K. M. Spooner, B. F. Baird, J. F. Manishewitz, H. S. Jaffe, P. F. Fisher, J. Falloon, R. T. Davey, Jr., J. A. Kovacs, R. E. Walker, S. M. Whitcup, R. B. Nussenblatt, H. C. Lane, and H. Masur: Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39, 882-886 (1995).
4. H.-T. Ho, J. J. Bronson, H. De Boeck, J. C. Martin, and M. J. M. Hitchcock: Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41, 197-202 (1991).
5. T. Cihlar, I. Votruba, K. Horska, R. Liboska, I. Rosenberg, and A. Holy: Metabolism of 1-(S)-(3-hydroxy-2-phosphonomethoxypropyl)-cytosine (HPMPC) in human embryonic lung cells. Collect. Czech. Chem. Commun. 57, 661-672 (1992).
6. E. R. Kern: Value of animal models to evaluate agents with potential against human cytomegalovirus. Transplant. Proc. 23, 152-155 (1992).
7. K. C. Cundy, Z.-H. Li, and W. A. Lee: Effect of concomitant probenecid on the tissue distribution and urinary excretion of HPMPC in preclinical models. Pharm. Res. 11 (Suppl.), S449 (1994).
8. J. W. Russell, M. J. M. Hitchcock, and L. J. Klunk: Pharmacology/ pharmacokinetics of a new antiviral agent: (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (S-HPMPC). Pharm. Res. 8 (Suppl.), S285 (1991).
9. K. C. Cundy, B. P. Petty, J. Flaherty, P. E. Fisher, M. A. Polis, M. Wachsman, P. S. Lietman, M. J. M. Hitchcock, and H. S. Jaffe: Clinical pharmacokinetics of cidofovir in HIV-infected patients. Antimicrob. Agents Chemother. 39, 1247-1252 (1995).
10. M. J. M. Hitchcock, S. A. Lacy, J. R. Lindsey, and E. R. Kern: The cyclic congener of cidofovir has reduced nephrotoxicity in three species. Antiviral Res. 26, A358 (1995).
11. N. Bischofberger, M. J. M. Hitchcock, M. S. Chen, K. C. Cundy, D. Barkhimer, K. M. Kent, S. A. Lacy, W. A. Lee, Z.-H. Li, M. Louie, D. B. Mendel, D. S. Smee, and J. L. Smith: Cyclic HPMPC: an intracellular prodrug for HPMPC with improved therapeutic index in vivo. Antimicrob. Agents Chemother. 38, 2387-2391 (1994).
12. A. Holy and I. Rosenberg: Synthesis of 9-(2-phosphonylmethoxyethyl)-adenine and related compounds. Collect. Czech. Chem. Commun. 52, 2801-2809 (1987).
13. Statistical Consultants, Inc.: "PCNONLIN®, Version 4.2. Software for the Statistical Analysis of Nonlinear Models and Micros." Statistical Consultants, Inc., Lexington, KY, 1993.
14. J. P. Holt and E. A. Rhode: Similarity of renal glomerular hemodynamics in mammals. Am. Heart J. 92, 465-472 (1976).
15. W. A. Lee, J.-P. Shaw, A. M. Bidgood, G. Lynch, E. Eisenberg, and K. C. Cundy: Tissue distribution and bioavailability of cyclic HPMPC, an intracellular prodrug of HPMPC. Antiviral Res. 26, A340 (1995).